Related Experiment Video

Updated: Aug 8, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Acquired hepatocerebral degeneration in hepatitis C infection

Nasir Khokhar1, Arsalan Ahmad, Muhammad Mansoor Butt

  • 1Department of Medicine, Division of Gastroenterology and Neurology, Shifa International Hospital / College of Medicine, Islamabad. drnkhokhar@yahoo.com

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|February 26, 2005
PubMed

Insights

Neurological complications like acquired hepatocerebral degeneration (AHCD) are rare in chronic liver disease (CLD). This case highlights a patient with hepatitis C virus (HCV) infection who developed serious AHCD complications.

Area of Science:

  • Hepatology
  • Neurology
  • Virology

Background:

  • Chronic liver disease (CLD) can lead to various neurological issues.
  • Hepatic encephalopathy is a common, reversible neurological complication of CLD.
  • Acquired hepatocerebral degeneration (AHCD) is a rare, irreversible neurological complication.

Observation:

  • This report details a patient with hepatitis C virus (HCV) infection.
  • The patient presented with symptoms indicative of acquired hepatocerebral degeneration (AHCD).
  • AHCD is infrequently documented in the context of HCV infection.

Findings:

  • The patient with HCV infection developed acquired hepatocerebral degeneration (AHCD).
  • The development of AHCD in this HCV patient led to severe complications.
  • This case adds to the limited literature on AHCD in HCV patients.

Implications:

  • This case underscores the potential for rare neurological complications in HCV patients.
  • It highlights the importance of recognizing AHCD in the differential diagnosis of neurological symptoms in CLD.
  • Further research may be needed to understand the mechanisms and management of AHCD in HCV infection.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...